411 related articles for article (PubMed ID: 6094211)
1. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
Dray A; Metsch R
Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
3. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
Dray A; Nunan L; Wire W
Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
[TBL] [Abstract][Full Text] [Related]
4. Selective delta-opioid receptor antagonism by ICI 174,864 in the central nervous system.
Dray A; Nunan L
Peptides; 1984; 5(5):1015-6. PubMed ID: 6095215
[TBL] [Abstract][Full Text] [Related]
5. Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats.
Pazos A; Flórez J
Eur J Pharmacol; 1983 Feb; 87(2-3):309-14. PubMed ID: 6301857
[TBL] [Abstract][Full Text] [Related]
6. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
Tortella FC; Robles L; Mosberg HI
J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of urinary bladder contractions by a spinal action of morphine and other opioids.
Dray A; Metsch R
J Pharmacol Exp Ther; 1984 Nov; 231(2):254-60. PubMed ID: 6092610
[TBL] [Abstract][Full Text] [Related]
8. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
Sbacchi M; La Regina A; Petrillo P; Tavani A
NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
[TBL] [Abstract][Full Text] [Related]
9. Centrally administered beta-endorphin produces prolonged changes in delta-opioid ligand activity in vivo.
Dray A; Nunan L; Wire W
Eur J Pharmacol; 1986 Jan; 120(3):359-62. PubMed ID: 3005007
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y depresses reflex urinary bladder contractions in rats and modifies central activity of opioid agonists.
Dray A; Nunan L; Wire W
Peptides; 1986; 7(2):323-9. PubMed ID: 3755528
[TBL] [Abstract][Full Text] [Related]
11. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
Tavani A; Petrillo P; La Regina A; Sbacchi M
J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
[TBL] [Abstract][Full Text] [Related]
12. Evidence that naloxonazine produces prolonged antagonism of central delta opioid receptor activity in vivo.
Dray A; Nunan L
Brain Res; 1984 Dec; 323(1):123-7. PubMed ID: 6098329
[TBL] [Abstract][Full Text] [Related]
13. Morphine and enkephalins potently inhibit [3H]noradrenaline release from rat brain cortex synaptosomes: further evidence for a presynaptic localization of mu-opioid receptors.
Mulder AH; Hogenboom F; Wardeh G; Schoffelmeer AN
J Neurochem; 1987 Apr; 48(4):1043-7. PubMed ID: 3029324
[TBL] [Abstract][Full Text] [Related]
14. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
15. Opiate receptors in neuronal primary cultures.
Eriksson PS; Hansson E; Rönnbäck L
Neuropharmacology; 1990 Sep; 29(9):799-804. PubMed ID: 1963478
[TBL] [Abstract][Full Text] [Related]
16. The mu rather than the delta subtype of opioid receptors appears to be involved in enkephalin-induced analgesia.
Chaillet P; Coulaud A; Zajac JM; Fournie-Zaluski MC; Costentin J; Roques BP
Eur J Pharmacol; 1984 May; 101(1-2):83-90. PubMed ID: 6086366
[TBL] [Abstract][Full Text] [Related]
17. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
[TBL] [Abstract][Full Text] [Related]
19. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
Van Vliet BJ; Mulder AH; Schoffelmeer AN
J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
[TBL] [Abstract][Full Text] [Related]
20. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
Hatzoglou A; Bakogeorgou E; Castanas E
Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
